Prognostic impact of corticosteroid and tocilizumab use on the efficacy of chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma Meeting Abstract
| Authors: | Costa, B.; Flynn, J.; Nath, K.; Nishimura, N.; Devlin, S.; Farzana, T.; Chung, D.; Landau, H.; Lahoud, O.; Scordo, M.; Shah, G.; Hassoun, H.; Maclachlan, K.; Hultcrantz, M.; Korde, N.; Lesokhin, A.; Shah, U.; Tan, C. R.; Giralt, S.; Usmani, S.; Mailankody, S. |
| Abstract Title: | Prognostic impact of corticosteroid and tocilizumab use on the efficacy of chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma |
| Meeting Title: | 20th Annual Meeting and Exposition of the International Myeloma Society |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 23 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Sep 27-30 |
| Meeting Location: | Athens, Greece |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-09-01 |
| Start Page: | S36 |
| Language: | English |
| ACCESSION: | WOS:001079705400059 |
| PROVIDER: | wos |
| DOI: | 10.1016/S2152-2650(23)01625-7 |
| Notes: | Meeting Abstract: P-007 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
